Ginkgo Bioworks DNA Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price at other companies

ClearPoint NeuroCLPT

——

Twist Bioscience CorporationTWST

——

Guardant HealthGH

——

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price?: Ginkgo Bioworks (DNA) reported share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price of $24.74 in Q1 2026.
How has Ginkgo Bioworks's share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price changed year-over-year?: Ginkgo Bioworks's share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price decreased by 74.1% year-over-year, from $95.35 to $24.74.